ARCA Biopharma Financials

ARCA Biopharma Stock Summary

ARCA Biopharma competes with Aerovate Therapeutics, Adagene, Acrivon Therapeutics,, Rezolute, and AN2 Therapeutics. ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. The company was incorporated in 2004 and is headquartered in Westminster, Colorado. Arca Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 17 people.

ARCA Biopharma Key Financial Ratios

ARCA Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ARCA Biopharma's current stock value. Our valuation model uses many indicators to compare ARCA Biopharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ARCA Biopharma competition to find correlations between indicators driving ARCA Biopharma's intrinsic value. More Info.ARCA Biopharma is rated second in return on equity category among its peers. It is rated fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ARCA Biopharma's earnings, one of the primary drivers of an investment's value.

ARCA Biopharma Market Pulse

Along with financial statement analysis, the daily predictive indicators of ARCA Biopharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ARCA Biopharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of ARCA Biopharma based on widely used predictive technical indicators. In general, we focus on analyzing ARCA Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ARCA Biopharma's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

If you are still planning to invest in ARCA Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ARCA Biopharma's history and understand the potential risks before investing.